Cambio interim report Q3 2025

Cambio continues to execute on our strategy to enable tomorrow’s health and social care, today. During the quarter we reached two important milestones. First, Region Sörmland went live within the Sussa collaboration in September, which means eight out of the nine Sussa regions are now operating on Cambio COSMIC. Second, we went live in Finland with our customer Åland in September, including the local municipalities. This marked a swift implementation from contract award in Q2 2024 to go-live just over a year later and further strengthened our Nordic footprint.

Quarterly highlights, July - September 2025

• Revenue amounted to 290.2 (273.9) MSEK in the third quarter, representing growth of 6.0%
• Adjusted EBITDA amounted to 40.8 (59.3) MSEK, representing growth of -31.2%
• Income before tax amounted to -42.6 (-15.3) MSEK
• Net income per share was negative (neg)

Please see our quarterly report for more insights.

For further information, please contact: 

Rami Avidan
CEO
+46 070 793 483 
rami.avidan@cambio.se

Johannes Fabó
CFO
+46 730 599 368
johannes.fabo@cambio.se

Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.